Otsuka Holdings
4578.T
#750
Rank
NZ$53.88 B
Marketcap
NZ$102.02
Share price
0.21%
Change (1 day)
3.47%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Otsuka Holdings (4578.T) - Total debt

Total debt on the balance sheet as of June 2025 : NZ$2.54 Billion

According to Otsuka Holdings 's latest financial reports the company's total debt is NZ$2.54 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Otsuka Holdings - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$2.13 B-10.98%
2023-12-31NZ$2.40 B2.81%
2022-12-31NZ$2.33 B-13.54%
2021-12-31NZ$2.70 B-11.03%
2020-12-31NZ$3.03 B-12.05%
2019-12-31NZ$3.45 B19.51%
2018-12-31NZ$2.89 B-4.19%
2017-12-31NZ$3.01 B-10.66%
2016-12-31NZ$3.37 B-11.56%
2015-12-31NZ$3.81 B277.17%
2014-12-31NZ$1.01 B
2014-03-31NZ$0.84 B0.32%
2013-03-31NZ$0.84 B-23.02%
2012-03-31NZ$1.09 B-24.94%
2011-03-31NZ$1.45 B-28.98%
2010-03-31NZ$2.05 B-17.69%
2009-03-31NZ$2.49 B